Previous studies have suggested that γ-aminobutyric acid-B (GABA B ) receptor agonists effectively reduce ethanol intake. The quantification using real-time polymerase chain reaction of Gabbr1 and Gabbr2 mRNA from the prefrontal cortex, hypothalamus, hippocampus, and striatum in mice exposed to an animal model of the addiction developed in our laboratory was performed to evaluate the involvement of the GABA B receptor in ethanol consumption. We used outbred, Swiss mice exposed to a three-bottle free-choice model (water, 5% v/v ethanol, and 10% v/v ethanol) that consisted of four phases: acquisition (AC), withdrawal (W), reexposure (RE), and quinine-adulteration (AD). Based on individual ethanol intake, the mice were classified into three groups: "addicted" (A group; preference for ethanol and persistent consumption during all phases), "heavy" (H group; preference for ethanol and a reduction in ethanol intake in the AD phase compared to AC phase), and "light" (L group; preference for water during all phases). In the prefrontal cortex in the A group, we found high Gabbr1 and Gabbr2 transcription levels, with significantly higher Gabbr1 transcription levels compared with the C (ethanol-naive control mice), L, and H groups. In the hippocampus in the A group, Gabbr2 mRNA levels were significantly lower compared with the C, L, and H groups. In the striatum, we found a significant increase in Gabbr1 transcription levels compared with the C, L, and H groups. No differences in Gabbr1 or Gabbr2 transcription levels were observed in the hypothalamus among groups. In summary, Gabbr1 and Gabbr2 transcription levels were altered in cerebral areas related to drug taking only in mice behaviorally classified as "addicted" drinkers, suggesting that these genes may contribute to high and persistent ethanol consumption.
Introduction
Central γ-aminobutyric acid (GABA) neurotransmission is a sensitive target for both the acute and chronic effects of ethanol (Lovinger, 2008) . Although several studies have investigated the neuroadaptations associated with ionotropic GABA A receptors after ethanol use (for review, see Enoch, 2008) , the neuroadaptations of metabotropic GABA B receptors need to be clarified.
Human studies have revealed the efficacy of baclofen (β-parachlorophenol GABA, a GABA B receptor agonist) in reducing ethanol intake and the compulsive desire for ethanol in dependent individuals (Addolorato et al., 2002; Flannery et al., 2004 ), but no difference was found in the efficacy of baclofen in other clinical study (Garbutt et al., 2010) although recently Muzyk et al. (2012) reported higher rates of abstinence and lower anxiety scores in baclofen-treated patients.
A reduction in ethanol consumption was observed in Sardinian alcohol-preferring (sP) rats after acute baclofen administration (Maccioni et al., 2005) . Baclofen also suppressed the ethanol deprivation effect in rats exposed to ethanol for 8 weeks (Colombo et al., 2003a (Colombo et al., , 2003b . C57BL/6J mice exhibited increased ethanol consumption after repeated baclofen administration (Moore et al., 2007) , although baclofen microinjection into the anterior ventral tegmental area reduced binge-like ethanol intake in the same strain (Moore and Boehm, 2009) .
In summary, baclofen, a GABA B agonist, reduces ethanol intake in animals and humans, but the contrary or no effect was also reported.
Some authors have demonstrated that conformational alteration of the GABA B1 subunit and subsequently conformational alteration of the entire GABA B1 -GABA B2 complex is necessary for effective activation of the GABA B receptor (Morishita et al., 1990) . Consequently, the precise balance between the two subunits is necessary for the activation of the receptor. One question is how this disproportional receptor subtype expression can support a basis for research on individualizing treatment.
A human study showed no significant association between GABBR1 gene polymorphisms and alcoholism (Köhnke et al., 2006) . However, another analysis suggested a possible association between GABBR1 and some groups of alcoholics (Sander et al., 1999) . Recently, a significant association between GABBR1 and GABBR2 and nicotine dependence was demonstrated in an American sample, suggesting a possible correlation between these genes and addictive behavior (Li et al., 2009) .
The GABA B receptor comprises two protein subunits, GB1 and GB2, encoded by the Gabbr1 and Gabbr2 genes, respectively. Although the Gabbr1 gene has various isoforms, the most widely expressed isoforms in the central nervous system are Gabbr1a and Gabbr1b, which are differentiated by the presence of a sequence that codifies two sushi domains (short consensus repeats, SCR or CPs) in the GB1 protein (Kaupmann et al., 1997; Hawrot et al., 1998) .
The GABA B receptor can be found as a heterodimer (GB1a/GB2 or GB1b/GB2), and both subunits are essential for GABA B function (Margeta-Mitrovic et al., 2001; Misgeld et al., 1995; Bowery et al., 2002; Bettler et al., 2004; Jones et al., 1998; Chen and van den Pol, 1998; Filippov et al., 2000) . Presynaptically, the GABA B receptor inhibits dopaminergic, GABAergic, and glutamatergic systems, and alterations in these systems are well known to be associated with addictive behavior (for review, see Koob et al., 1998; Everitt and Robbins, 2005; Kalivas and Volkow, 2005; Le Moal and Koob, 2007) .
To understand the influence of genes on ethanol intake, some rodent models that use genetic selection have been used and have contributed to a better comprehension of alcoholism, but their results have been inconclusive (Green and Grahame, 2008) . A question that arises from the interpretation of studies that involve selective breeding or inbreeding is whether high-drinking lines exhibit greater ethanol-reinforced behavior than low-drinking lines. Moreover, some animal studies may lack many aspects of human alcoholism, such as compulsive drug use, which is characteristic of addiction and central to the clinical diagnosis of dependence (American Psychiatric Association, 1994) . Addiction is defined as compulsive drug use despite negative consequences. In recent years, new animal models have been developed and proposed for the study of compulsive drug use (i.e., craving or persistent desire for drug), relapse, and loss of control, which are specific components of human addiction (Heyman, 2000; Phillips, 2002; Shippenberg and Koob, 2002; Spanagel, 2003; Camarini et al., 2010) .
The animal model used in the present study was proposed initially for rats by Wolffgramm and Heyne (1995) and validated for mice in our laboratory (Fachin-Scheit et al., 2006) . We previously demonstrated the model's reliability, face validity (long-term high ethanol intake and ethanol preference over 4 months, considering the whole life of a mouse, and persistent intake despite bitter taste adulteration of ethanol solutions), and predictive validity (when tested with naltrexone as a pharmacological challenge, mice reduced ethanol intake (Fachin-Scheit et al., 2006; Ribeiro et al., 2008; Correia et al., 2009) . The behavioral analysis of fluid intake in mice exposed to a freechoice model was accomplished, and two phenotypes exhibited high ethanol consumption and preference for ethanol during almost the entire treatment (i.e., great behavioral similarity). During the last 2 weeks of the model when ethanol was adulterated with quinine, some high-drinker mice significantly reduced their ethanol intake, whereas others continued to show the same consumption. The "loss of control over the ingestion of ethanol" suggestive of "addiction" (Spanagel, 2009) can be examined in this model only for some mice when ethanol solutions are made "less palatable" by the addition of a quinine solution.
Drug addiction behavior involves different components of the neuronal circuitry like the prefrontal cortex (related with the reinstatement of drug seeking), hippocampus (recognition of contextual conditioned stimuli associated to the drug), hypothalamus (neuroendocrine control), and striatum (related to the drug's rewarding effects). Each of these areas plays a different role in functions related to addictive behavior (for review, see Kalivas and Volkow, 2005; Everitt and Robbins, 2005) , with different transcription and protein profiles.
Considering (i) the participation of GABA B receptors in ethanol consumption; (ii) the reduction in ethanol consumption under baclofen treatment; (iii) the increase in Gabbr2 protein in nicotine addiction; (iv) the differential participation of brain structures in the neurobiology of drug-taking behavior; and (v) our validated ethanol consumption model provides an alternative approach to the study of addictive behaviors and to the individual ethanol intake profiles, we hypothesized that "addicted" mice might have an increase in Gabbr1 and Gabbr2 transcription levels in those brain areas related to addictive behavior when compared to non-addicted mice (heavy-drinking and lightdrinking mice). Thus, the increased GABAB activity would lead to greater inhibition in dopamine release in nucleus accumbens, increasing the rewarding value of ethanol for those mice due to the increased ethanol-induced dopamine release by other mechanisms.
Materials and methods

Animals
Eighty naive 6-week-old Swiss male mice that weighed 20-30 g from the Universidade Federal do Paraná were used in this study. The mice were housed individually (20 × 30 × 20 cm) under a 12 h/ 12 h light/dark cycle (lights on at 07:00 h) and controlled temperature (22°C ± 2°C), with ad libitum access to food (Purina Laboratories, Curitiba, Brazil). One week before the treatments, the mice underwent an acclimation period, and water intake and body weight were measured. All procedures were performed during the light cycle. Experimental care and treatment were approved by the Ethics Committee for Animal Experimentation of the Setor de Ciências Biológicas (Protocol Number: 281), Universidade Federal do Paraná.
Experimental design
Extended chronic ethanol intake
One group of mice (n = 60) was exposed to three-bottle freechoice treatment for 10 weeks (acquisition [AC] phase), during which they had free access to both 10% and 5% (v/v) ethanol and water. Another group of control animals (n = 20) only had access to water during all phases of the experiment. The experimental design is summarized in Fig. 1 . The positions of the bottles were changed on alternate days when fluid intake was measured volumetrically. Over the next 2 weeks, only water was provided [withdrawal (W) phase]. For the following 2 weeks, the ethanol solutions were again offered to establish free-choice responding among the ethanol solutions and water [reexposure (RE) phase]. At the end of this period, the ethanol solutions were adulterated with 0.005 g/L quinine, which produces a bitter-tasting solution, and offered to the animals for a further 2 week period [adulteration (AD) phase]. This quinine concentration was chosen through an analysis of dose-response using other mice, in which the 0.005 g/L concentration of quinine significantly reduced its intake compared with water intake without completely inhibiting response (Fachin-Scheit et al., 2006) , suggesting an "aversive-like" effect. This dose-response analyze was based on daily administration of different quinine concentration to different groups of mice (n= 10 per concentration) during seven days. The water and quinine solution consumptions (mL) were performed after 24 h (Table 1) .
At the end of the exposition to the 3-bottle free choice paradigm, the mice were classified into groups based on their individual patterns of ethanol preference and consumption. Firstly, we evaluated the preference between total ethanol intake (mL) and water consumption during each phase for each mouse. Those mice preferring water during all phases were classified as "light-drinker" (group L). Those mice preferring ethanol during AC were, then, evaluated regarding their individual ethanol consumption (g/kg/day) along the phases: those ones maintaining [i.e., no significant decrease] the ethanol intake when ethanol solutions were added quinine (AD phase) were classified as "addicted" (group A); and those ones with decreased ethanol consumption during the AD phase compared to AC phase were classified as "heavy-drinker" (group H). The animals that did not conform strictly to any of these patterns were excluded from subsequent analyses ( Table 2) .
Molecular analysis
At the end of the free-choice ethanol experiment (week 17), mice were euthanized by decapitation, and four brain regions were dissected on ice: prefrontal cortex, hypothalamus, hippocampus, and striatum (the latter two from both hemispheres; Paxinos and Franklin, 2001 ). The structures were conditioned in 1 mL RNAlater® (Ambion-Qiagen, São Paulo, Brazil) and then frozen at −80°C. All mice had continuous free-choice access to ethanol until decapitation.
For the RNA extraction, the samples immersed in RNAlater® were thawed, and total RNA was extracted using TRizol® according to the manufacturer's protocol (Invitrogen, São Paulo, Brazil). Samples were quantified using NanoDrop® ND-1000v3 1.0 (Thermo Fisher Scientific, Waltham, MA, USA), and RNA integrity was visualized in 1% agarose gel stained with ethidium bromide. The minimum acceptable 260/280 nm ratio was 1.7.
The reverse transcription was performed in a total volume of 20 μL using 2 μg of total RNA and oligo (dT 20 ) primers (Prodimol Biotecnologia, Belo Horizonte, Brazil). SuperScriptIII® (Invitrogen, São Paulo, Brazil) was used according to the manufacturer's protocol.
To the Real-time PCR, the reactions were performed in a RotorGene 3000 (Corbett Life Science, Concord, Australia) utilizing SYBR® Green PCR Master Mix (Applied Biosystems, São Paulo, Brazil). Polymerase chain reaction (PCR) amplification was performed without the extension step (95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 60 s). Fluorescence acquisition was measured in the last step of each cycle (60°C).
Data were analyzed using RG-3000 (Corbett Life Science) software and a Microsoft Excel spreadsheet. The minimum acceptable correlation coefficient was 0.90. In all reactions, a negative control without sample was tested. Melting curves were examined to guarantee the absence of any spurious products. To normalize mRNA levels, three reference genes (Gapdh, glyceraldehyde 3-phosphate dehydrogenase; B-act, β-actin; Ppia, peptidylprolyl isomerase A) were used, and the relative quantity (Vandesompele et al., 2002) was calculated for the Gabbr1 and Gabbr2 genes.
Primer design
Exon sequences were obtained from the National Center for Biotechnology Information database (http://www.ncbi.nlm.nih.gov; accessed August 12, 2011). Primer sequences were designed using Primer3 v.0.4.0 (Rozen and Skaletsky, 2000) , and the quality and specificity of the primer pairs were examined using NetPrimer (http://www. premierbiosoft.com/netprimer/netprlaunch/netprlaunch.html; accessed August 12, 2011) and Primer-BLAST (http://www.ncbi.nlm.nih.gov/ tools/primer-blast/index.cgi?LINK_LOC=BlastHome; accessed August 12, 2011), respectively. All primers were positioned in inter-exon regions. Although it was not possible to distinguish among the different isoforms of the Gabbr1 gene, the isoforms most widely expressed in the central nervous system, Gabbr1a and Gabbr1b, were covered by selecting a primer pair which anneals to both isoforms. Primers were synthesized by Prodimol (Prodimol Biotecnologia, Belo Horizonte, Brazil). The primers had the following sequences: Gabbr1 F , 5′-TCC-ACCAACAACAATGAGGA-3′; Gabbr1 R , 5′-GATGGCGCAGTTCAGAGAC-3′; Gabbr2 F , 5′-GAGGACATCAACTCCCCAGA-3′; and Gabbr2 R , 5′-CTGGCT-GTAGGGCTGACAC-3′. For the reference genes, primer sequences were designed and tested as previously described (Bibancos et al., 2007) .
Blood ethanol concentration (BEC)
Fifty microliter microcapillary tubes were used to collect retroorbital blood samples at the end of the experiment (at the end of the AD phase), during the light cycle, after mice from A, H and L Fig. 1 . Experimental design. Methods for assessing loss of control over ethanol ingestion in mice (Correia et al., 2009; Fachin-Scheit et al., 2006 ). The intake model runs for 16 weeks and is divided into four phases. Over the course of a 10 week period (acquisition phase), experimental mice have a free choice among 0% (i.e., water vehicle), 5%, and 10% ethanol. Control animals have access only to water. After this period, ethanol solutions are removed for 2 weeks (withdrawal phase), and mice have access only to water. The ethanol solutions are then offered again for 2 weeks (reexposure phase). In the final 2 weeks phase (adulteration phase), ethanol solutions are adulterated with quinine hydrochloride (0.005 g/L). Day Fluid choice Fluid intake (mL/day) 1 Quinine 3.2 ± 0.61 2.8 ± 0.63 1.6 ± 0.43*** 1.3 ± 0.39*** Water 3.6 ± 0.56 4.4 ± 0.76 4.6 ± 0.60 6.7 ± 0.67 2 Quinine 2.6 ± 0.62 1.8 ± 0.76* 1.8 ± 0.59** 0.7 ± 0.30*** Water 3.4 ± 0.54 4.0 ± 0.80 5.2 ± 0.76 6.8 ± 0.68 3 Quinine 2.6 ± 0.62 2.4 ± 0.62* 0.5 ± 0.22*** 1.0 ± 0.47*** Water 4.0 ± 0.60 4.6 ± 0.86 5.8 ± 0.25 6.2 ± 0.55 4 Quinine 1.8 ± 0.32*** 0.5 ± 0.22*** 1.4 ± 0.37*** 0.6 ± 0.22*** Water 4.1 ± 0.46 6.0 ± 0.52 5.8 ± 0.57 6.6 ± 0.70 5 Quinine 2.7 ± 0.76 1.9 ± 0.84* 0.6 ± 0.22*** 0.6 ± 0.22*** Water 3.4 ± 0.64 4.5 ± 0.87 6.3 ± 0.49 6.5 ± 0.65 6 Quinine 2.9 ± 0.71 2.2 ± 0.69* 0.9 ± 0.10*** 0.9 ± 0.18*** Water 3.7 ± 0.65 4.7 ± 0.92 6.3 ± 0.52 6.9 ± 0.60 7 Quinine 2.5 ± 0.85 1.7 ± 0.67** 1.1 ± 0.10*** 1.3 ± 0.26*** Water 4.6 ± 0.76 5.2 ± 0.87 6.0 ± 0.54 6.4 ± 0.58
Daily fluid intake during a 1 week period based on a choice between water and a bittertasting solution containing different concentrations of quinine. Data are expressed as mean ± SEM for different groups of mice for each quinine concentration (n = 10 per concentration). *p ≤ 0.05, **p ≤ 0.005, ***p ≤ 0.001, significant difference between quinine and water intake for each day and each concentration (Student's t-test for independent samples).
groups were exposed to free-choice for one more week in order to allow the return to their previous intake profiles. Samples were centrifuged and plasma was decanted and stored at −80°C until the BEC determination. BEC was achieved using an Analox Alcohol Analyzer (Analox Instruments, Lunenburg, MA).
Statistical analysis
Data were analyzed for distribution normality using the KolmogorovSmirnov test and homogeneity of variance using Levene's test. Body weight in grams and ethanol intake in milliliters were used to compute the grams of ethanol intake per kilogram of body weight (g/kg). Ethanol and water consumption were expressed as the daily mean and standard error. To classify each mouse accordingly to its ethanol intake pattern we considered the individual preference between total ethanol intake (mL) and water intake and also, the individual ethanol consumption in g/kg/day in each phase: firstly, the preference between water and total ethanol intake (mL) in each phase was detected through t-test for each mouse, then, ANOVA analysis with repeated measures followed by the Newman-Keuls multiple range post hoc test for each animal to compare individual consumption throughout the phases by considering the daily consumption for each phase (i.e., 14 measures in the AC phase, 14 measures in the RE phase, and 14 measures in the AD phase). The individual data and respective analyses used for classification regarding each mouse are presented here in Table 2 .
After the classification of mice into three groups (A, H, and L), the ANOVA followed by the Newman-Keuls test was used to compare the groups and phases for ethanol consumption (g/kg/day).
The normalized relative quantity of mRNA was compared using one-way ANOVA followed by the Newman-Keuls post hoc test for each brain area in all groups. Within each group, an independent t-test was used to compare the mRNA levels of the Gabbr1 and Gabbr2 genes. Both GABA-B receptor subunits' mRNA values were compared and normalized to the control genes. Values of p b 0.05 were considered statistically significant. Analyses were performed using STATISTICA 6.1 software (StatSoft, Sao Caetano do Sul, Brazil). BEC data were expressed as mg/mL of ethanol and were analyzed by ANOVA followed by Tukey's test. All analyses were performed using STATISTICA 6.1 software (StatSoft, Sao Caetano do Sul, Brazil). Differences were considered significant at p ≤ 0.05.
Results
Extended chronic ethanol
Group classification based on individual consumption
Mice that were exposed to the free-choice paradigm were classified into three groups according to their individual water or ethanol drinking patterns: "addicted" (A group, n = 13), "heavy" (H group, n = 11), and "light" (L group, n = 21). Three animals were excluded during the dissection procedure, one died, and the other eleven did not meet the classification criteria (e.g., one mouse preferred water during the AC phase and ethanol during the AD phase). These animals were not included in the subsequent analyses. Animals from the A and H groups consumed more ethanol (g/kg) than animals from the L group during all phases (F AC(2,25) = 42.32, p b 0.0001; F RE(2,25) = 45.24, p b 0.0001; F AD(2,25) = 15.82, p b 0.0001). In the RE phase, the H group exhibited significantly lower ethanol consumption than the A group (p b 0.05). During the AC phase, the H group consumed more ethanol than the A group (p b 0.05). Comparisons among phases showed that the H group exhibited significantly lower ethanol intake throughout the phases subsequent to withdrawal (p b 0.001), whereas the A group showed a constant rate of consumption (F 4,50 = 19.22, p b 0.0001). The L group exhibited low ethanol intake during all phases, and no differences were observed (Fig. 2) .
No difference in water intake (mean mL/day and SEM) was observed among the different groups during the acclimation period prior to exposure to the free-choice model (C, 6.7-0.48; L, 6.1-0.32; H, 7.1-0.9; A, 6.3-0.48; F 3,28 = 0.72943, p > 0.05). The L group consumed significantly more water than the A and H groups, but one- Individual's analysis of ethanol intake during the experimental phases (considering the last 2 weeks of the acquisition phase, and the reexposure and adulteration phases). Values represent means and SEM of ethanol intake (g/kg/day) and water intake (mL/day). Symbols represent significant differences for each animal: *p b 0. 
Molecular analysis
Only material that was in good condition was used for the molecular analysis, consisting of 6-8 control mice, 7-8 L mice, 6-7 H mice, and 5-7 A mice.
One-way ANOVA revealed a group effect for the Gabbr1 gene (F 3,24 = 5.67, p b 0.01) in the prefrontal cortex. The post hoc comparison showed that the A group had increased mRNA levels compared with the other groups. The t-test revealed no significant differences for each group for the levels of Gabbr1 and Gabbr2 transcripts (Fig. 3) .
In the hippocampus Gabbr2 transcription levels were lower in the A group compared with the other groups (F 3,23 = 3.87, p b 0.05). A significant difference was found between the transcription levels of the Gabbr1 and Gabbr2 genes only in the A group (t = 2.93, p b 0.05; Fig. 3) .
No difference was observed in mRNA levels among groups (Gabbr1: F 3,26 = 0.70, p > 0.05; Gabbr2: F 3,23 = 1.18, p > 0.05) in the hypothalamus. For the A, H, and L groups, Gabbr1 transcription levels were significantly higher than Gabbr2 transcription levels (LD: t = 4.00, p b 0.05; HD: t = 2.12, p b 0.05; PH: t = 2.57, p b 0.05). A similar profile was observed in the C group, but the difference was not significant (Fig. 3) .
Comparisons among groups revealed increased Gabbr1 transcription levels in the A group (F 3,23 = 4.40, p b 0.05) and no difference in Gabbr2 transcription levels (F 3,23 = 1.05, p > 0.05) in the striatum. All groups exhibited Gabbr1 mRNA levels that were higher than Gabbr2 mRNA levels, but the difference was significant only in the A group (t = 4.00, p b 0.05; Fig. 3 ).
Blood ethanol concentration (BEC)
BEC values were expressed as mean (mg/mL) and standard deviation for each group: group A (1.13 ± 0.32), group H (0.79 ± 0.56) and group L (0.48 ± 0.42). ANOVA followed by Tukey's test showed that group A presented higher BEC than group L (F 2,20 = 3.80, p b 0.05).
Discussion
The main finding from the present study was the confirmation of the proposed hypothesis that "addicted" mice would have high Gabbr1 and Gabbr2 transcription levels in brain areas related to addictive behaviors. Indeed, mice behaviorally classified as "addicted" drinkers (A group) have higher Gabbr1 transcription levels compared with the C (ethanol-naive control mice), L, and H groups in the prefrontal cortex and in the striatum. In the hippocampus, the A group showed lower Gabbr2 mRNA levels than the C, L, and H groups. In summary, Gabbr1 and Gabbr2 transcription levels were altered in cerebral areas related to drug taking only in mice behaviorally classified as addicted drinkers, suggesting that these genes may contribute to high and persistent ethanol consumption despite "aversive" condition.
Animal model
Gabbr1 and Gabbr2 transcription can be found altered to a greater or lesser degree depending on the specific central nervous system region (Misgeld et al., 1995; Bettler et al., 2004) . Here, we raised the hypothesis that ethanol consumption observed in the present study, which are phenotypic manifestation, may have been related to genotypic differences among groups. We demonstrated that the genes that encode the GABA B1 and GABA B2 subunits were differentially expressed in mice that exhibited a "addicted" profile just in brain areas which have been proposed by many authors (Kalivas and Volkow, 2005; Everitt and Robbins, 2005) to be related to addictive behavior. The animals from group A compared to the other two groups: had higher Gabbr1 and Gabbr2 transcription levels in the prefrontal cortex; lower Gabbr2 mRNA levels in the hippocampus and higher Gabbr1 transcription levels in the striatum. How these differences in transcription levels may account for differences in ethanol consumption is still unknown.
Despite the inherent limitations of any animal model that proposes to mimic addiction, the present model has already been demonstrated to be a reliable model because it reflects the "natural development" of ethanol consumption (Wolffgramm and Heyne, 1995) and provides stable classification criteria based on individual analysis like diagnosis in humans. The model incorporates a "natural" development in the progression from initiation to "loss of control" of ethanol consumption, which is observed only in some individuals, like seen in humans too. We previously demonstrated the model's reliability, which was replicated 10 times, and the same proportions of mice that exhibited the differential intake profiles were always found (about 18 to 25% are group A; 18 to 30% are group H and 28 to 35% are group L). The model has proven face validity (long-term high ethanol intake, heightened anxiety during ethanol withdrawal and persistent intake despite adulteration of ethanol solutions with quinine) and also, has predictive validity when tested with naltrexone as a pharmacological challenge (Camarini et al., 2010; Correia et al., 2009; Fachin-Scheit et al., 2006; Ribeiro et al., 2008) . One limitation to be considered in this study is the lack of positive control regarding the aversiveness of quinine. One might consider testing the preference between quinine-containing alcohol solution versus alcohol solution aiming to discard some preference for quinine adulterated solutions in each group, although quinine is known to be a bittertasting substance that produces a strong aversion in rodents (Aravich and Sclafani, 1980) . However, this limitation does not compromise the validity and reliability of the model. Wolffgramm and Heyne (1995) suggested that exposing the animal to "aversive" phases (i.e., withdrawal and adulteration) allows the assessment of voluntary intake after and under unpleasant conditions. Unlike in rat studies (Spanagel and Hölter, 1999; Wolffgramm and Heyne, 1995), our "addicted" (A group) mice exhibited no increase in ethanol consumption after withdrawal (ethanol deprivation effect). Moreover, the A group showed no preference for either of the two concentrations of ethanol solutions, although when assessed individually, some mice preferred one solution over the other during all phases. Perhaps some characteristics of the mouse strain utilized in the present study influenced the manifestation of these behaviors. Nevertheless, preference and high ethanol intake did not vary between phases, indicating a persistent neuroadaptation related to such behaviors in animals with impaired control on ethanol intake. Additionally, the model incorporates the "natural" progression from the initiation of ethanol consumption to persistent ethanol consumption despite the bitter taste (which may be indicative of "loss of control," a hallmark of addictive behavior in humans) using outbred mice. Animals classified as heavy drinkers (H group) exhibited high ethanol preference during the acquisition phase and a significant reduction in ethanol consumption after the withdrawal phase, suggesting that adaptations developed during acquisition did not induce persistent ethanol consumption.
The difference between the A and H groups was persistent ethanol intake during the adulteration phase (i.e., no significant reduction in ethanol consumption in this phase, reflected by intra-group comparisons in the A group). No difference was found in voluntary ethanol intake during this phase between these groups (i.e., reflected by intergroup comparisons). Thus, we suggest that molecular differences may result from innate susceptibility to the effects of ethanol (i.e., individual variations). The ethanol consumption in the "addicted" mice (A group) reached 9.5 ± 0.8 g/kg/day in the AC phase and 11.4 ± 0.9 g/kg/day in the AD phase, whereas ethanol consumption in the light-drinker mice (L group) reached 4.2 ± 0.5 g/kg/day and 5.7 ± 0.7 g/kg/day, respectively. Heilig and Koob (2007) mentioned that laboratory rodents do not voluntarily consume ethanol to the point of intoxication, and even when masking the taste of ethanol with a sweetener, which is faded out as ethanol concentrations are increased, rats that have not been bred for high ethanol preference rarely consume more than 2 g ethanol/kg/day, and blood ethanol concentrations required for dependence are rarely achieved. However, some genetically rodent lines under certain conditions (Crabbe et al., 2009; Murphy et al., 2002; McBride and Li, 1998) voluntarily exceed BECs of 100 mg%, which is considered an intoxication level. In our present study, we observed that "addicted" mice exhibited average BEC above this limit, i.e. 113 mg%.
Mice classified as light drinkers (L group) showed no changes in ethanol intake across the experimental phases. These mice exhibited water preference and low ethanol consumption. Indeed, even under stressful situations (e.g., isolation, ethanol exposure and withdrawal), these animals did not develop ethanol preference, in contrast to the A and H groups. Thus, mice in the L group may present behavioral and biological features that prevent the manifestation of behaviors that Fig. 3 . GABA B receptor genes in specifics brain areas. Bars represent mean ± SEM of Gabbr1 (br1) and Gabbr2 (br2) gene transcripts for each group. Prefrontal cortex (C, n = 8; L, n = 7; H, n = 6; A, n = 7). Hippocampus (C, n = 6; L, n = 8; H, n = 6; A, n = 7). Hypothalamus (C, n = 8; L, n = 8; H, n = 6; A, n = 5). Striatum (C, n = 7; L, n = 8; H, n = 7; A, n = 5). *p b 0.05, significantly different from the other groups (one-way ANOVA followed by Newman-Keuls post hoc test); # p b 0.05, significantly different from the other gene in the same group (independent t-test). Both GABA-B receptor subunits mRNA values were compared and normalized to the control genes. Animals: C, controls; L, light drinkers; H, heavy drinkers; A, addicted drinkers. lead to ethanol consumption (i.e., preference for ethanol or persistent ethanol intake). We may also consider that this group is a possible control for the free-choice experiment.
Transcriptional profile of Gabbr1 and Gabbr2 genes
Our results demonstrated that the transcriptional profiles of GABA B receptor genes were different depending on the brain area analyzed. Each of these areas plays a different role in functions related to addictive behavior (for review, see Kalivas and Volkow, 2005; Everitt and Robbins, 2005) , with different transcription and protein profiles. Chemical sensitivity tends to be distinct among cerebral areas. The prefrontal cortex and striatum may be considered less sensitive to ethanol compared with other regions. However, the possibility that the transcription levels of both genes might indeed decrease in response to continued stimulus exposure, similar to the hippocampus, cannot be excluded.
The discrepancies between Gabbr1 and Gabbr2 mRNA levels in the hypothalamus and striatum, and the linearity between these transcripts in the prefrontal cortex and hippocampus are consistent with other observations in rats and humans (Jones et al., 1998; Clark et al., 2000; Berthele et al., 2001; Martin et al., 2004) . However, our results demonstrated a more pronounced difference between Gabbr1 and Gabbr2 mRNA levels in the hippocampus and striatum, which could reflect a possible alteration in the transcriptional homeostasis (i.e., disequilibrium) of these genes in the A group.
An increase in mRNA levels of both genes was observed in the prefrontal cortex, and was significant for Gabbr1 in the A group. An analysis of the brains of alcoholic humans revealed an increase in GABBR1 transcription levels compared with control subjects (Flatscher-Bader et al., 2005) . The prefrontal cortex is involved in decision making (Bush et al., 2002) and plays an important role in the transition from voluntary actions to compulsion to drug addiction (for review, see Everitt and Robbins, 2005) . Moreover, the prefrontal cortex is associated with the response to predictability of rewarding stimuli (Berns et al., 2001 ). The significant increases in transcription levels in the prefrontal cortex observed only in the A group could be related to the "loss of control" over ethanol intake because if this increase is observed equally in all mice, one can conclude that this is an ethanol-induced effect.
The hippocampus is associated with the motivational impact of contextual stimuli on drug seeking (for review, see Everitt and Robbins, 2005) . Hippocampal glutamatergic afferents to the nucleus accumbens modulate the increases in mesoaccumbens dopamine release and therefore can influence responses that are mediated by limbic structures (Floresco et al., 2001) . In contrast to the observations in the prefrontal cortex in the present study, a reduction in Gabbr1 and Gabbr2 transcription levels was observed in the hippocampus, reaching significance for the latter gene in the A group. A study that utilized rats subjected to chronic ethanol treatment found a reduction in GABA release, an effect possibly modulated by presynaptic GABA B receptors in the hippocampus (Peris et al., 1997) . Other studies have demonstrated that ethanol facilitates the function of presynaptic GABA B receptors in the CA1 area of the hippocampus (Frye and Fincher, 1996; Wan et al., 1996; Ariwodola and Weiner, 2004) . However, in a study that used rats exposed to chronic cocaine treatment, GABA B receptor desensitization was found after 3 drug-free weeks. Furthermore, GABAergic tone increased, suggesting a possible loss of presynaptic GABA B receptor activity (Xi et al., 2003) . Although the role of GABA B receptors in addictive behavior is still unclear, altered activity of this receptor may interfere with glutamatergic and dopaminergic circuits in this brain region, which may have contributed to the maintenance of the drug-taking behavior observed in our mice that exhibited persistent ethanol consumption.
The A group exhibited higher Gabbr1 mRNA levels in the striatum compared with the other groups. Previous studies have demonstrated that increases in dopamine in the striatum in humans are associated with the reinforcing effects of stimulants (for review, see Kalivas and Volkow, 2005) , suggesting that the increase in dopamine levels might be more related to the motivation to obtain the drug than to the pleasure evoked by the drug. Gabbr1 knockout mice showed increased extracellular dopamine levels in the striatum, and the release of these neurotransmitters was lower in knockouts than in wildtype mice after D-amphetamine administration (Vacher et al., 2006) . These results suggest that GABAergic tone might be important for the maintenance of dopaminergic circuit homeostasis involved in drug-taking behavior.
Although the hypothalamus has considerable concentrations of Gabbr1 and Gabbr2 transcripts, no significant changes were found among the groups of ethanol consumers. This brain region regulates ingestive behaviors and has projections to limbic structures. Furthermore, hypothalamic function plays an important role in disorders related to ethanol use.
Regardless of the GABAergic influence on glucose metabolism, we found no differences in the mRNA levels of glyceraldehyde 3-phosphate-dehydrogenase (i.e., the reference gene) in any of the areas analyzed, which is consistent with Eravci et al. (1999) . However, other studies have found altered gene expression related to glucose metabolism in the hippocampus in alcoholic humans (MatsudaMatsumoto et al., 2007) and altered transcription levels in the hippocampus of animals after chronicle ethanol consumption (Hargreaves et al., 2009) . Further studies are necessary to clarify the cross-talk between these systems and their relationships with ethanol addiction.
Interestingly, light-drinker mice (L group) demonstrated no alterations in Gabbr1 and Gabbr2 mRNA levels, and their transcriptional profiles were similar to the control group. This phenotype, therefore, may provide useful information about possible protector genes and may thus help us understand the mechanisms that underlie the prevention of disorders related to excessive ethanol intake.
Establishing a direct association between transcription and gene expression is difficult. Therefore, a simple increase or decrease in specific mRNAs may not represent a direct gene effect on the phenotype. Moreover, we cannot be sure if the purported differences in gene expression existed before ethanol drinking, are a consequence of such drinking, or are consequence of some combination of both. These data reflect a possible association between Gabbr1 and Gabbr2 genes and the loss of control of ethanol intake. However, such disturbances could indicate that transcriptional homeostasis in the brain is related to the maintenance of persistent drug-taking behavior in these mice. Thus, continuous stimuli that alter transcription levels or the genetic transcription of a specific isoform can influence the regulatory mechanisms of gene expression (e.g., by non-coding RNAs that alter alternative splicing) and consequently interfere with synaptic plasticity (Huang et al., 2005; Li et al., 2007) . Understanding these modulatory mechanisms will aid in better comprehending the neural control of persistent ethanol consumption.
Based on the present results, Gabbr1 and Gabbr2 transcript levels were altered in cerebral areas crucially related to drug-taking behavior only in mice phenotypically classified as addicted drinkers. In this sense, we conducted an experiment to determine the effect of a GABA B agonist in these animals considering a model of human addiction, a good model to assess individual responses to a given treatment. Nevertheless, additional studies are necessary to clarify the regulatory mechanisms that may interfere with gene transcription and consequently the conservation of high and persistent ethanol intake. 
